Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yunnan Baiyao for postoperative brain protection in moderate to severe traumatic brain injury
ChiCTR2000030280Phase 4Recruiting
- Sponsor
- Department of Neurosurgery, First Medical Center of the Chinese PLA General Hospital
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Yunnan Baiyao in traumatic brain injury (TBI) (4 arms), sponsored by Department of Neurosurgery, First Medical Center of the Chinese PLA General Hospital. Primary endpoints: Glasgow Coma Scale, Glasgow Outcome Scale and 3 more. Started Sep 2019; status: recruiting.
02
Drugs
Yunnan Baiyao
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ChiCTR2000030280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030280.